The present invention concerns the development of new pharmacologically active compounds for the treatment of osteoporosis and in general bone diseases characterized by progressive loss of bone mass, such as rheumatoid arthritis, hyperparathyroidism, and bone cancer metastases.

Settore:

Life sciences

Research Institution:

Università di Pisa

Publication number:

WO2016071863A1

Technologies, Systems, Applications:

New drugs development

Technological Priority:

Biomedical, pharmaceutical, pharmacological technologies
Pubblicato il:
Torna in cima alla pagina